ontxw expiration 5 years after issuance
http://files.shareholder.com/downloads/AMDA-1XRSSC/0x0xS1047469-16-14224/1130598/filing.pdf
Onconova Therapeutics, Inc.
We are distributing to holders of our common stock and to holders of certain of our outstanding warrants who are entitled to participate in this offering, at no charge, non-transferabl
subscription rights to purchase units. Each unit, which we refer to as a Unit, consists of one share of common stock and 0.75 of a tradable warrant representing the right to purchase one share of
common stock, which we refer to as the Warrants. We refer to the offering that is the subject of this prospectus as the Rights Offering.
In the Rights Offering, you will receive 1.5 subscription rights for each share of common stock or each share of common stock underlying our participating warrants owned at 5:00 PM Eastern
Time, on July 7, 2016, the record date of the Rights Offering, or the Record Date. The common stock and the Warrants comprising the Units will separate upon the effectiveness of the exercise of the
rights and will be issued as separate securities, and the Units will not trade as a separate security. The subscription rights will not be tradable.
Each subscription right will entitle you to purchase one Unit, which we refer to as the Basic Subscription Right, at a subscription price per Unit of $4.90, which we refer to as the Subscription
Price. The Warrants entitle the holder to purchase one share of common stock at an exercise price of $5.88 per share, 120% of the per Unit price, from the date of issuance through its expiration five
years after the date of issuance. If you exercise your Basic Subscription Rights in full, and other shareholders or participating warrant holders do not, you will be entitled to an over-subscription
privilege to purchase a portion of the unsubscribed Units at the Subscription Price, subject to proration, which we refer to as the Over-Subscription Privilege. Each subscription right consists of a
Basic Subscription Right and an Over-Subscription Privilege, which we refer to as the Subscription Right
News 
Market Data 
Discover 
